428 Interim analysis of Phase 2 results for cemiplimab in patients with metastatic basal cell carcinoma (mBCC) who progressed on or are intolerant to hedgehog inhibitors (HHIs)

• Marcus Butler,
• Rogerio Neves,
• Lisa Licitra,
• Israel Lowy,
• Zeynep Eroglu,
• Karl Lewis,
• Leonel Hernandez-Aya,
• Axel Hauschild,
• Emmanuel Okoye,
• Siyu Li,
• Jean-Francois Baurain,
• Oliver Bechter,
• Ketty Peris,
• Aleksandar Sekulic,
• Alexander Stratigos,
• Lara Dunn,
• Anne Lynn Chang,
• Michael Migden,
• Kosalai Mohan,
• Ebony Coates,
• Emily Ruiz,
• Frank Seebach,
• David Weinreich,
• George Yancopoulos,
• Timothy Bowler,
• Matthew Fury

Affiliations

Marcus Butler

2Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Rogerio Neves

Aff366 grid.29857.310000000120974281Pennsylvania State University, Hershey Cancer Institute Hershey PA USA

Lisa Licitra

Aff9 0000 0001 0807 2568grid.417893.0Fondazione IRCCS Istituto Nazionale dei Tumori Milan and University of Milan Milan Italy

Israel Lowy

Aff4 grid.419971.3Medarex, Bloomsbury, NJ/Bristol-Myers Squibb Company Wallingford CT USA

Zeynep Eroglu

Aff6 grid.468198.a0000000098915233Department of Cutaneous OncologyMoffitt Cancer Center 12902 USF Magnolia Drive 33612 Tampa FL USA

Karl Lewis

6University of Colorado, Aurora, CO, USA

Leonel Hernandez-Aya

8 Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA

Axel Hauschild

11 Department of Dermatology, University Hospital (UKSH), Kiel, Germany

Emmanuel Okoye

19 Regeneron Pharmaceuticals, Inc, London, UK

Siyu Li

21 Regeneron Pharmaceuticals, Inc, Basking Ridge, New Jersey, USA

Jean-Francois Baurain

7Université Catholique de Louvain and Cliniques Universitaires Saint-Luc

Oliver Bechter

1University Hospitals Leuven, Leuven, Belgium

Ketty Peris

2Catholic University of the Sacred Heart and Fondazione Policlinico Universitario A. Gemelli-IRCCS, Rome, Italy

Aleksandar Sekulic

3Arizona Mayo Clinic, Arizona, AZ, USA

Alexander Stratigos

4Andreas Sygros Hospital-National and Kapodistrian University of Athens, Athens, Greece

Lara Dunn

5Memorial Sloan Kettering Cancer Center, New York, NY, USA

Anne Lynn Chang

7Stanford University School of Medicine, Stanford, CA, USA

Michael Migden

8University of Texas MD Anderson Cancer Center, Houston, TX, USA

Kosalai Mohan

9Regeneron Pharmaceuticals, Inc., Basking Ridge, NJ, USA

Ebony Coates

9Regeneron Pharmaceuticals, Inc., Basking Ridge, NJ, USA

Emily Ruiz

17Dana-Farber Cancer Institute, Boston, MA, USA

Frank Seebach

9Regeneron Pharmaceuticals, Inc., Basking Ridge, NJ, USA

David Weinreich

9Regeneron Pharmaceuticals, Inc., Basking Ridge, NJ, USA

George Yancopoulos

9Regeneron Pharmaceuticals, Inc., Basking Ridge, NJ, USA

Timothy Bowler

9Regeneron Pharmaceuticals, Inc., Basking Ridge, NJ, USA

Matthew Fury

9Regeneron Pharmaceuticals, Inc., Basking Ridge, NJ, USA